Effectiveness of behavioral activation on adversity quotient, experimental avoidance, and emotion regulation in patients with multiple sclerosis
AQ and experimental avoidance in patients with MS
DOI:
https://doi.org/10.22122/cdj.v11i4.738Keywords:
Imagery, Psychotherapy, Adversity, Behavior, Emotional Regulation, Multiple SclerosisAbstract
BACKGROUND: Patients with multiple sclerosis (MS) experience a lack of integration in psychological, social, emotional, and physical dimensions, and in addition to physical problems, they experience a variety of psychological problems in the cognitive-emotional aspect as a result of the disease-caused cognitive-emotional disorder. The present study aimed to investigate the effect of behavioral activation combined with guided imagery rescripting on adversity quotient (AQ), experimental avoidance, and cognitive emotion regulation in patients with MS.
METHODS: This was a research with a quasi-experimental design (pre-test and post-test with a control group). The statistical population included all patients with MS visiting the Caspian Physiotherapy Center of Ahvaz, Iran, in 2020. The sample consisted of 30 patients with MS (15 in the experimental group and 15 in the control group) who were selected by convenience sampling. The research instruments included the Adversity Quotient Test, Young-Rygh Avoidance Inventory (YRAI), and the Cognitive Emotion Regulation Questionnaire (CERQ). Analysis of covariance (ANCOVA) was used to analyze the data.
RESULTS: Behavioral activation combined with guided imagery rescripting increased AQ and positive cognitive emotion regulation, and decreased experiential avoidance and negative cognitive emotion regulation in patients with MS in the experimental group compared to the control group (P < 0.001).
CONCLUSION: Behavioral activation combined with guided imagery rescripting could be an effective method for increasing AQ and positive cognitive emotion regulation and decreasing experiential avoidance and negative cognitive emotion regulation in patients with MS.
References
Mirmosayyeb O, Shaygannejad V, Bagherieh S, Hosseinabadi AM, Ghajarzadeh M. Prevalence of multiple sclerosis (MS) in Iran: A systematic review and meta-analysis. Neurol Sci. 2022; 43(1): 233-41.
Gil-Gonzalez I, Martin-Rodriguez A, Conrad R, Perez-San-Gregorio MA. Quality of life in adults with multiple sclerosis: A systematic review. BMJ Open. 2020; 10(11): e041249.
Ebrahimi A, Ghahari S. The effectiveness of mindfulness-based stress reduction (MBSR) on anxiety and depression in patients with multiple sclerosis (MS). Chron Dis J. 2020; 8(1): 21-5.
Turner AP, Knowles LM. Behavioral Interventions in Multiple Sclerosis. Fed Pract. 2020; 37(Suppl 1): S31-S35.
Longinetti E, Frisell T, Englund S, Reutfors J, Fang F, Piehl F. Risk of depression in multiple sclerosis across disease-modifying therapies. Mult Scler. 2022; 28(4): 632-41.
Case LK, Jackson P, Kinkel R, Mills PJ. Guided imagery improves mood, fatigue, and quality of life in individuals with multiple sclerosis: An exploratory efficacy trial of healing light guided imagery. J Evid Based Integr Med. 2018; 23: 2515690X17748744.
Safi'i A, Muttaqin I, Sukino, Hamzah N, Chotimah C, Junaris I, et al. The effect of the adversity quotient on student performance, student learning autonomy and student achievement in the COVID-19 pandemic era: Evidence from Indonesia. Heliyon. 2021; 7(12): e08510.
Potter KJ, Golijana-Moghaddam N, Evangelou N, Mhizha-Murira JR, das Nair R. Self-help acceptance and commitment therapy for carers of people with multiple sclerosis: A feasibility randomised controlled trial. J Clin Psychol Med Settings. 2021; 28(2): 279-94.
Donisi V, Gajofatto A, Mazzi MA, Gobbin F, Busch IM, Ghellere A, et al. Insights for fostering resilience in young adults with multiple sclerosis in the aftermath of the COVID-19 emergency: An Italian survey. Front Psychiatry. 2020; 11: 588275.
Tavakoli Saleh S, Ebrahimi ME. Effectivenes of acceptance-commitment therapy on the resillience and psycological well-being of female patients with multiple sclerosis in Hamadan, Iran. Avicenna J Clin Med. 2021; 28(2): 126-33.
Grothe M, Opolka M, Berneiser J, Dressel A. Testing social cognition in multiple sclerosis: Difference between emotion recognition and theory of mind and its influence on quality of life. Brain Behav. 2021; 11(1): e01925.
Sahin E, Gulec KS, Terzi M. The effect of a psychoeducation program based on the rational emotional behavioral approach in individuals with multiple sclerosis diagnosis: A randomized controlled trial. Perspect Psychiatr. Care 2022; 58(4): 1449-59.
Lotfi S, Aminipozveh Z. The effectiveness of emotion-regulation skills training on blood pressure control and quality of life in patients with hypertension. Chron Dis J. 2020; 8(1): 8-13.
Schirda B, Duraney E, Lee HK, Manglani HR, Andridge RR, Plate A, et al. Mindfulness training for emotion dysregulation in multiple sclerosis: A pilot randomized controlled trial. Rehabil Psychol. 2020; 65(3): 206-18.
Ratajska A, Zurawski J, Healy B, Glanz BI. Computerized cognitive behavioral therapy for treatment of depression in multiple sclerosis: a narrative review of current findings and future directions. Int J MS Care. 2019; 21(3): 113-23.
Filipi M, Jack S. Interferons in the treatment of multiple sclerosis: A clinical efficacy, safety, and tolerability update. Int J MS Care. 2020; 22(4): 165-72.
Seid SH, Rajaei A, Borjali M. Comparing the effectiveness of behavioral activation treatment with anger management on the identity crisis of patients with multiple sclerosis. Journal of Research in Psychological Health. 2020; 13(4): 1-14.
D'Elia A, Bawor M, Dennis BB, Bhatt M, Litke K, McCabe K, et al. Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: The BRAVE pilot trial. Pilot Feasibility Stud. 2020; 6: 61.
Amiri S, Ehteshamzadeh P, Hafezi F, Borna M. Comparing the effectiveness of behavioral activation and acceptance and commitment therapy in cognitive-attentional syndrome in patients with depression. Middle East J Rehabil Health Stud. 2021; 8(2): e109550.
Case LK, Jackson P, Kinkel R, Mills PJ. Guided imagery improves mood, fatigue, and quality of life in individuals with multiple sclerosis: An exploratory efficacy trial of healing light guided imagery. J Evid Based Integr Med. 2018; 23: 2515690X17748744.
Maier A, Schaitz C, Kroner J, Connemann B, Sosic-Vasic Z. Imagery rescripting: exploratory evaluation of a short intervention to reduce test anxiety in university students. Front Psychiatry. 2020; 11: 84.
Wang X, Liu M, Tee S, Dai H. Analysis of adversity quotient of nursing students in Macao: A cross-section and correlation study. Int J Nurs Sci. 2021; 8(2): 204-9.
Tamizi M, Rezai A, Kazemi S. Coefficient (AQ) difficult relationship and difficulties in social emotional regulation efficient: The criminals fund AF - correcting township Shiraz. Crime Prevention Studies. 2015; 10(36): 9-30.
Soleimani sefat E, Saadati H, Azimian S, Amani S, Saleh manijeh H, Leshni L. Psychometric Properties of Persian Version of Young-Rygh Avoidance Inventory. Iran J Psychiatry Clin Psychol. 2017; 23(2): 232-43.
Garnefski N, Kraaij V. Cognitive emotion regulation questionnaire- development of a short 18-item version (CERQ-short). Pers Individ Dif. 2006; 41(6): 1045-53.
Badie A, Makvandi B, Bakhtiarpour S, Pasha R. Drug cravings and its relationship with family communication patterns and resiliency through the mediatory role of difficulty in cognitive emotion regulation. Journal of Client-Centered Nursing Care. 2020; 6(2): 125-34.
Shahabi A, Ehteshamzadeh P, Asgari P, Makvandi B. Comparison of the effectiveness of acceptance and commitment therapy and guided imagery on the resilience of cardiac disease patients referring to the heart rehabilitation department. The Horizon of Medical Sciences. 2020; 26(3): 276-97.
Serrano-Ibanez ER, Ramirez-Maestre C, Lopez-Martinez AE, Esteve R, Ruiz-Parraga GT, Jensen MP. Behavioral inhibition and activation systems, and emotional regulation in individuals with chronic musculoskeletal pain. Front Psychiatry. 2018; 9: 394.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chronic Diseases Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
